IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
In vitro efficacy of anti-HSV drugs on breast cancer cells MCF-7 & MDA-MB- 231 - A drug repurposing approach

Author: VASUDHA ANISETTY, ASHISH WADHWANI, DIVYABHARATHI MANI, PRAVEEN T.K, VIRAL PATEL, SRIKANTH JUPUDI
Abstract: Breast cancer, a most common cancer in the women worldwide representing about quarter (25%) of all cancers. The predictions of cancer prevalence show an imperative need for strengthening the present diagnostic/treatment facilities. One such strategy to overcome the treatment burden for the breast cancer is drug repurposing/repositioning. This concept has been growing its importance, the very reason behind this is it decreases significantly the funds needed for the development of therapy for a disease and it increases the chances of the new indications from Phase I to entry in the market. The objective of the study was to evaluated the morphological characteristic, migration features of the cells and cell cycle arrest of the anti-HSV drug Acyclovir against breast cancer cell lines MCF-7 and MDA-MB231. The in vitro cytotoxicity studies, fragmentation assay, long term clonogenic assay and cell cycle analysis were carried out in the study. In MTT assay acyclovir showed IC50 of 3.16 ± 1.10µg/ml and 3.85 ± 1.54µg/ml respectively with SI of 33.46 tested against MCF-7 and MDAMB-231 cell lines. The platting efficiency was found to be 52.30 % by clonogenic assay. One of the indications of cell death by apoptosis is accumulation of cells in G2/M phase which was observed with Acyclovir in cell cycle analysis. The study showed that Acyclovir inhibited cancer cells propagation, colony formation ability and cell cycle arrest at G2/M phase, while having no effect on the normal cells. These results indicated new insights on the effect of anti-HSV agents on the tumorigenesis and metastasis.
Keyword: Acyclovir; Antiviral; Breast cancer; Drug repurposing/repositioning
DOI: https://doi.org/10.31838/ijpr/2020.12.02.0056
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free